Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD

NCT06405100 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Minimal Change Disease

Interventions

DRUG: Supportive care+Prednisone
DRUG: Supportive care+Tacrolimus+Ripertamab
DRUG: Supportive care+Ripertamab

Sponsor

Air Force Military Medical University, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]